Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence

The research conducted for this Article complied with all relevant ethical regulations. The experiments were approved by the MGH Institutional Animal Care and Use Committee (IACUC) under protocol no. 2021N000135 and performed according to MGH…